- SetPoint Medical is a commercial-stage medical technology company focused on developing neuroimmune modulation therapies for chronic autoimmune diseases, particularly rheumatoid arthritis, with a first-in-class FDA-approved device, the SetPoint System.
- In the past year, SetPoint Medical raised $140 million in private financing, including a $115 million Series D round, and expanded its leadership team to support the commercialization of its rheumatoid arthritis therapy.
- The company recently performed its first SetPoint System procedure in Texas at Ascension Dell Seton Medical Center, highlighting its growing partnerships with healthcare providers to enhance patient access to innovative therapies.
- SetPoint Medical's ideal buyers are healthcare providers and payers looking for effective treatment options for patients with moderate-to-severe rheumatoid arthritis who have not responded to traditional therapies, making their innovative solutions particularly relevant in today's market.
Setpoint's workforce is organized across six departments, with a notable concentration in Information Technology, which employs 15 individuals. The Executive department follows with 7 employees, indicating a strong leadership presence. Operations and Other departments also contribute significantly to the overall headcount, with 6 and 13 employees, respectively. This distribution reflects a balanced functional mix essential for effective software development.
Setpoint operates across three locations, with the largest workforce based in Ogden, UT, housing 16 employees. The other locations, Orlando, FL, and Torrance, CA, each have a single employee, suggesting a minimal presence in these areas. The 'Other' category accounts for 28 employees, indicating a distributed workforce model that may include remote or flexible working arrangements. This geographic distribution highlights a concentration in Ogden while maintaining a diverse operational footprint.
